Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

about

Antiretroviral therapy: effects on orofacial health and health care.Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors.Fatal outcome of nevirapine-associated toxic epidermal necrolysis.

P2860

Q38093238-46880A02-000E-4CA3-BA03-A5B39E384C49 Q43410386-B75AFE1D-DD93-42F5-87C1-98EEBCAF596D Q46412365-24BC82F2-3DB5-449C-B898-684257D6BB6B

P2860

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

Item

http://www.wikidata.org/entity/Q36103159

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@ast

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@en

type

Item

label

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@ast

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@en

prefLabel

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@ast

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@en

P1476

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

@en

P2093

Heidi H Kong

http://www.w3.org/2001/XMLSchema#string

Sarah A Myers

http://www.w3.org/2001/XMLSchema#string

P2860

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

Zidovudine-induced leukocytoclastic vasculitis

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Viral dynamics in human immunodeficiency virus type 1 infection

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Immune restoration disease after antiretroviral therapy.

Hypersensitivity of zidovudine: report of a case of anaphylaxis and review of the literature.

P304

58-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1529-8019.2005.05004.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15842613

http://www.w3.org/2001/XMLSchema#string

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

about

P2860

P2860

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698